Pay in 4 interest-free payments of $5.14 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
FDA concerns for compounding
Prevent release into water systems
Heart rate increase: about 5-10 bpm above baseline, peaking near week 24, then declining
reuteri AMBV339 is currently in clinical evaluation for its impact on the gut and vaginal microbiome and metabolome upon administration as an oral dietary supplement (ClinicalTrials.gov ID NCT06425081) 36
The result may be a stronger, more consistent growth hormone pulse than either peptide produces alone
Paying modestly more for a product with verified purity and proper documentation proves worthwhile compared to the risks and wasted effort associated with substandard compounds
US$ 27.68
US$ 27.14
US$ 25.79
US$ 26.62
US$ 24.91
US$ 29.15
US$ 29.61
US$ 28.06
US$ 25.60
